参考文献/References:
[1] Aggarwal A, Brown KA, Lewinter MM. Diastolic dysfunction:Pathophysiology, clinical features, and assessment with radionuclide methods[J]. J Nucl Cardiol, 2001,8:98-106.
[2] Senior R, Kaul S, Raval U, et al. Demonstration of reversible ischaemia is a better predictor of functional recovery after revascularization than presence of cellular variability alone in ischemic cardiomyopathy[J]. Eur Heart J, 1997, 18:245.
[3] Taylor MD, Wallhaus TR, DeGrado TR, et al. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in patients with congestive heart failure[J]. J Nucl Med, 2001, 42:55-62.
[4] Bengel FM, Permanetter B, Ungerer M, et al. Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate-comparison between the normal and failing human heart[J]. Eur J Nucl Med, 2000, 27:319-326.
[5] Beanlands RS, Nahmias C, Gordon E, et al. Beta blocker therpy improves cardiac efficiency in patients with left ventricular dysfunction[J]. Circulation, 1999, 100:1-26.
[6] He ZX, Medrano R, Mahmarian JJ, et al. Nitroglycerin-augmented thallium-201 reinjection enhances detection of reversible myocardial hypoperfusion:A randomized, doubleblind, parallel, placebo-controlled trial[J]. Circulation, 1997, 95:1799-1805.
[7] Pagley PR, Belier GA, Watson DD, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability[J]. Circulation, 1997, 96:793-800.
[8] Elefteriades JA, Morales DLS, Gradel C, et al. Results of cornary artery bypass grafting by a single surgeon in patients with left ventricular ejection fraction ≤30%[J]. Am J Cardiol, 1997, 79:1573-1578.
[9] Lotze U, Kaepplinger S, Kober A, et al. Recovery of the cardiac adrenergic nervous system after long-term β-blocker therapy in idiopathic cilated cardiomyopathy:assessment by increase in myocardial metaiodobenzylguanidine uptake[J]. J Nucl Med, 2001, 42:49-54.
[10] Yamazaki J, Muto H, Kabano T, et al. Evaluation of β-blocker therapy in patients with dilated cardiomyopathy-Clinical meaning of iodine -123-metaiodobenzylguanidine myocardial single-photon emission computed tomography[J]. Am Heart J, 2001, 4:645-652.
[11] Baliga RR, Narula J, Dec GW. The MIBG tarot:Is it possible to predict the efficacy of β-blockers in congestive heart failure?[J]. J Nucl Cardiol, 2001, 8:107-109.
[12] Merlet P, Pouillart F, Dubois-Rande JL, et al. Sympathetic nerve alterations assessed with 123I-MIBG in the failing human heart[J]. J Nucl Med, 1999, 40:224-231.
[13] Lahiri A. The role of cardiac imaging in optimizing therapy in heart failure[J]. J Nucl Cardiol, 2000, 7:81-84.
[14] Choi JY, Lee KH, Hong KP, et al. Iodine-123 MIBG imaging before treatment of heart failure with carvedilol to predict improvement of left ventricular function and exercise capacity[J]. J Nucl Cardiol, 2001, 8:4-9.
[15] Mack CA, Patel SR, Schwarz EA, et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart[J]. J Thorac Cardiovase Surg, 1998, 115(1):168-176.
[16] Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis:initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia[J]. Circulation, 1998, 98:2800-2804.
[17] Jamshidi Y, Montgomery HE, Hense HW, et al. Peroxisome proliferator-activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension[J]. Circulation, 2002, 105(8):950-955.
相似文献/References:
[1]邢宇,赵新明.放射性核素标记HER2亲和体分子探针精准诊疗的研究进展[J].国际放射医学核医学杂志,2016,40(2):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
Xing Yu,Zhao Xinming.Advances in radionuclide-labeled HER2 affibody molecular probes for precise diagnosis and treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):139.[doi:10.3760/cma.j.issn.1673-4114.2016.02.011]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]孙芳芳,张欣.uPAR放射性核素靶向显像研究进展[J].国际放射医学核医学杂志,2016,40(3):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
Sun Fangfang,Zhang Xin.Research progress of uPAR-targeted nuclear imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):230.[doi:10.3760/cma.j.issn.1673-4114.2016.03.013]
[5]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[6]黄建敏,解朋,刘晓梅,等.以整合素αvβ3为靶点的肿瘤分子显像及靶向治疗[J].国际放射医学核医学杂志,2015,39(3):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
Huang Jianmin,Xie Peng,Liu Xiaomei,et al.Integrins αvβ3 in molecular imaging and targeted therapy of neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):256.[doi:10.3760/cma.j.issn.1673-4114.2015.03.015]
[7]郭宵峰,刘建中,孙琦婷.肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究[J].国际放射医学核医学杂志,2015,39(4):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
Guo Xiaofeng,Liu Jianzhong,Sun Qiting.Comparative study of pulmonary ventilation/perfusion planar imaging and pulmonary perfusion SPECT combined with low-dose CT in the diagnosis of pulmonary embolism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
[8]马春旭,袁卫红.甲状腺结节影像学诊断研究进展[J].国际放射医学核医学杂志,2014,38(1):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
Ma Chunxu,Yuan Weihong.Advanced research on imaging diagnosis of thyroid nodule[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):48.[doi:10.3760/cma.j.issn 1673-4114.2014.01.010]
[9]吕靖,张一帆.核素分子显像监测胚胎干细胞及诱导性多潜能干细胞移植的研究进展[J].国际放射医学核医学杂志,2014,38(2):106.[doi:10.3760/cma.j.issn.1673-4114.2014.02.009]
Lyu Jing,Zhang Yifan.Advances in radionuclide imaging of monitoring embryonic stem cells and induced pluripotent stem cells transplantation[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):106.[doi:10.3760/cma.j.issn.1673-4114.2014.02.009]
[10]高平,王茜,赵赟赟,等.99Tcm-MDP SPECT/CT显像用于骨肉瘤肺转移的诊断[J].国际放射医学核医学杂志,2014,38(3):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
Gao Ping,Wang Qian,Zhao Yunyun,et al.99Tcm-MDP SPECT/CT used in diagnosis of pulmonary metastasis from osteosarcoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]